24
Participants
Start Date
January 21, 2019
Primary Completion Date
April 26, 2019
Study Completion Date
April 26, 2019
BI 730357
single rising oral dose
Placebo
single rising oral dose
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku
Lead Sponsor
Boehringer Ingelheim
INDUSTRY